Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa B Kimball

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
Journal of the American Academy of Dermatology|October 8, 2025
A randomized, double-blind, placebo-controlled phase 2 study of eltrekibart, a novel septa-specific monoclonal antibody to CXCR1/2 ligands, in adults with hidradenitis suppurativaSeth Forman, Dipak R Patel, Alexa B Kimball, et al.
Journal of the American Academy of Dermatology|September 29, 2025
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trialJames M Kilgour, Hal Landy, Alexa B Kimball, et al.
American Journal of Clinical Dermatology|June 28, 2023
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatmentJoel M Gelfand, Alexa B Kimball, Eliot N Mostow, et al.
Dermatology and Therapy|December 5, 2025
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK AnalysisApril W Armstrong, Richard B Warren, Howard Sofen, et al.
Journal of the American Academy of Dermatology|August 22, 2023
Wound care for patients with hidradenitis suppurativa: Recommendations of an international panel of expertsDivya Chopra, Nimay Anand, Shandi Brito, et al.
Archives of Dermatology|July 23, 2008
US dermatology residents' satisfaction with training and mentoring: survey results from the 2005 and 2006 Las Vegas Dermatology SeminarsScott R Freeman, Riley E Greene, Alexa B Kimball, et al.
Pediatric Dermatology|July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate AcneIsha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
American Journal of Clinical Dermatology|May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
American Journal of Clinical Dermatology|February 21, 2020
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical PracticeErrol P Prens, Aida M Lugo-Somolinos, Amy S Paller, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
Journal of the American Academy of Dermatology|October 8, 2025
A randomized, double-blind, placebo-controlled phase 2 study of eltrekibart, a novel septa-specific monoclonal antibody to CXCR1/2 ligands, in adults with hidradenitis suppurativaSeth Forman, Dipak R Patel, Alexa B Kimball, et al.
Journal of the American Academy of Dermatology|September 29, 2025
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trialJames M Kilgour, Hal Landy, Alexa B Kimball, et al.
American Journal of Clinical Dermatology|June 28, 2023
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatmentJoel M Gelfand, Alexa B Kimball, Eliot N Mostow, et al.
Dermatology and Therapy|December 5, 2025
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK AnalysisApril W Armstrong, Richard B Warren, Howard Sofen, et al.
Journal of the American Academy of Dermatology|August 22, 2023
Wound care for patients with hidradenitis suppurativa: Recommendations of an international panel of expertsDivya Chopra, Nimay Anand, Shandi Brito, et al.
Archives of Dermatology|July 23, 2008
US dermatology residents' satisfaction with training and mentoring: survey results from the 2005 and 2006 Las Vegas Dermatology SeminarsScott R Freeman, Riley E Greene, Alexa B Kimball, et al.
Pediatric Dermatology|July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate AcneIsha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
American Journal of Clinical Dermatology|May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort StudyAmit Garg, Yvonne Geissbühler, Emma Houchen, et al.
American Journal of Clinical Dermatology|February 21, 2020
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical PracticeErrol P Prens, Aida M Lugo-Somolinos, Amy S Paller, et al.
Pageof 23